Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « R. J. Motzer »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
R. J. Metz < R. J. Motzer < R. J. Mulholland  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
001241 (2014) B. Escudier [France] ; M. D. Michaelson [États-Unis] ; R. J. Motzer [États-Unis] ; T. E. Hutson [États-Unis] ; J. I. Clark [États-Unis] ; H. Y. Lim [Corée du Sud] ; E. Porfiri [Royaume-Uni] ; P. Zalewski [Canada] ; G. Kannourakis [Australie] ; M. Staehler [Allemagne] ; J. Tarazi [États-Unis] ; B. Rosbrook [États-Unis] ; L. Cisar [États-Unis] ; S. Hariharan [États-Unis] ; S. Kim [États-Unis] ; B. I. Rini [États-Unis]Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
002848 (2002) R. J. Motzer ; A. Rakhit ; J. Thompson [États-Unis] ; H. Gurney [Australie, Royaume-Uni] ; P. Selby [Australie, Royaume-Uni] ; R. Figlin [États-Unis] ; S. Negrier [France] ; S. Ernst [Canada] ; M. Siebels [Allemagne] ; M. Ginsberg ; K. Rittweger ; L. HooftmanPhase II trial of branched peginterferon-α 2a (40 kDa) for patients with advanced renal cell carcinoma

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Advanced stage
2Antineoplastic agent
2Carcinoma
2Chemotherapy
2Treatment
1Adverse events
1Alpha interferon
1Antiangiogenic agent
1Antineoplastic Agents (adverse effects)
1Antineoplastic Agents (therapeutic use)
1Antitumor activity
1Axitinib
1Best response
1Biological receptor
1Cancerology
1Carcinoma, Renal Cell (drug therapy)
1Carcinoma, Renal Cell (mortality)
1Carcinoma, Renal Cell (pathology)
1Chronic dosing
1Chronic hepatitis
1Clin oncol
1Clinical trial
1Cmax
1Comparative study
1Conjugated compound
1Controlled release form
1Cytokines (therapeutic use)
1Disease-Free Survival
1Dosage form
1Dose attenuation
1Dosing
1Dosing interval
1Ethylene oxide polymer
1Grawitz tumor
1Hepatic transaminase concentrations
1Human
1Humans
1Imidazoles (adverse effects)
1Imidazoles (therapeutic use)
1Immunological surrogates
1Indazoles (adverse effects)
1Indazoles (therapeutic use)
1Indoles (therapeutic use)
1Interferon
1Interferon alpha 2a
1Karnofsky performance status
1Key words: interferon-α, pegylated, renal cell carcinoma
1Kidney
1Kidney Neoplasms (drug therapy)
1Kidney Neoplasms (mortality)
1Kidney Neoplasms (pathology)
1Kidney cancer
1Lymph
1Lymph node
1Major response
1Malignant tumor
1Measurable disease
1Median time
1Memorial cancer center
1Modest survival benefit
1Multiple dosing
1Neopterin
1Niacinamide (adverse effects)
1Niacinamide (analogs & derivatives)
1Niacinamide (therapeutic use)
1Node
1Partial response
1Pharmacokinetic profile
1Pharmacokinetics
1Phase II trial
1Phase III trial
1Phenylurea Compounds (adverse effects)
1Phenylurea Compounds (therapeutic use)
1Protein Kinase Inhibitors (adverse effects)
1Protein Kinase Inhibitors (therapeutic use)
1Pyrroles (therapeutic use)
1Renal
1Renal cell carcinoma
1Serial venous blood samples
1Serum concentration
1Serum concentrations
1Serum levels
1Serum samples
1Sorafenib
1Stable disease
1Standard preparations
1Steady state
1Subcutaneous
1Subcutaneous administration
1Subcutaneous injection
1Tolerability profile
1Toxicity
1Toxicity profile
1Treatment Outcome
1Treatment efficiency
1Tumor Burden
1Untreated patients
1Vascular endothelium growth factor

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "R. J. Motzer" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "R. J. Motzer" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    R. J. Motzer
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024